ciprofloxacin has been researched along with Gram-Negative Bacterial Infections in 231 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study the effect of ciprofloxacin versus ceftazidime on concentrations of pro- and anti-inflammatory cytokines in the sera of patients with severe sepsis was evaluated." | 9.11 | Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. ( Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I, 2004) |
| "To compare meropenem with ciprofloxacin for treatment of gram-negative bacilli sepsis in penicillin-allergic patients in the intensive care unit (ICU) to determine if increased anaphylaxis risk with meropenem precluded its use when weighed against risks of inactive therapy with ciprofloxacin." | 8.87 | Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. ( Bolon, MK; Esterly, JS; Lee, TA; Postelnick, M; Reddy, P; Scheetz, MH, 2011) |
| "To evaluate the impact of cessation of ciprofloxacin prophylaxis during stem cell transplantation for multiple myeloma." | 7.91 | Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization. ( Gabalec, F; Paterova, P; Radocha, J; Zak, P; Zavrelova, A, 2019) |
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 7.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| "We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug." | 7.69 | Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996) |
| " Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn." | 6.67 | Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994) |
| "We report a case of surgical site infection with ciprofloxacin-resistant Aeromonas hydrophila following leech therapy." | 5.39 | Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. ( Bobenchik, AM; Deville, JG; Giltner, CL; Humphries, RM; Uslan, DZ, 2013) |
| " After a pre-intervention period, in which cefepime was used as the initial agent for febrile neutropenia, 4 primary antibiotics, namely, piperacillin-tazobactam, ciprofloxacin, meropenem, and cefepime, were rotated at 1-month intervals over 20 months." | 5.17 | Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. ( Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H, 2013) |
| "In the present study the effect of ciprofloxacin versus ceftazidime on concentrations of pro- and anti-inflammatory cytokines in the sera of patients with severe sepsis was evaluated." | 5.11 | Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. ( Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I, 2004) |
| "A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg." | 5.07 | Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. ( Pfau, A; Sacks, TG, 1993) |
| "Loperamide decreases the number of unformed stools and shortens the duration of diarrhea in dysentery caused by Shigella in adults treated with ciprofloxacin." | 5.07 | Ciprofloxacin and loperamide in the treatment of bacillary dysentery. ( Bodhidatta, L; Echeverria, P; Hoge, CW; Imlarp, S; Murphy, GS; Tamura, K; Tansuphaswadikul, S, 1993) |
| "To compare meropenem with ciprofloxacin for treatment of gram-negative bacilli sepsis in penicillin-allergic patients in the intensive care unit (ICU) to determine if increased anaphylaxis risk with meropenem precluded its use when weighed against risks of inactive therapy with ciprofloxacin." | 4.87 | Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. ( Bolon, MK; Esterly, JS; Lee, TA; Postelnick, M; Reddy, P; Scheetz, MH, 2011) |
| " The vast majority of Enterobacteriaceae, including ESBL producers, remain susceptible to carbapenems, and these agents are considered preferred empiric therapy for serious Enterobacteriaceae infections." | 4.83 | Resistance in gram-negative bacteria: enterobacteriaceae. ( Paterson, DL, 2006) |
| "To evaluate the impact of cessation of ciprofloxacin prophylaxis during stem cell transplantation for multiple myeloma." | 3.91 | Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization. ( Gabalec, F; Paterova, P; Radocha, J; Zak, P; Zavrelova, A, 2019) |
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 3.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| " The majority of gram-negative bacterial infections were multidrug resistant, but 17 of the 20 gram-negative bacteria were sensitive to meropenem." | 3.81 | Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. ( Albright, AL; Ferson, S; Ochieng', N; Okechi, H, 2015) |
| " Both he and his partner were treated with oral ciprofloxacin 500 mg bd for 6 weeks with clinical clearance of infection, but both developed a scarring alopecia." | 3.74 | A possible new cause of spa bath folliculitis: Aeromonas hydrophila. ( Mulholland, A; Yong-Gee, S, 2008) |
| " We evaluated retrospectively the effect of antibiotic prophylaxis with ciprofloxacin and penicillin on the prevention of bacterial infections in 112 cases of prolonged neutropenia in adult patients treated for haematological malignancies." | 3.70 | [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. ( Baumgartner, JD; Cometta, A; Delarive, P; Glauser, MP, 2000) |
| "We describe a 66-year-old woman with infective endocarditis due to Cardiobacterium hominis whose condition, complicated by severe aortic regurgitation and congestive heart failure, necessitated aortic valve replacement despite treatment with ceftriaxone followed by ciprofloxacin." | 3.70 | Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. ( Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ, 2000) |
| " In the UK chloramphenicol is commonly recommended as the drug of first choice for the treatment of superficial bacterial eye infections." | 3.69 | Fluoroquinolones for the eye. ( , 1994) |
| "Ciprofloxacin may be considered as first-line treatment for a number of infections in which gram-negative pathogens are proven or strongly suspected, including complicated urinary tract infections, bacterial prostatitis, bacterial diarrhea, selected bone and joint infections, malignant otitis externa, bronchopulmonary infections in patients with cystic fibrosis and selected pneumonia cases." | 3.69 | Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. ( Louie, TJ, 1994) |
| "We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug." | 3.69 | Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996) |
| " Currently, its use is off-label partly because of lack of pharmacokinetic studies." | 2.79 | Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. ( Castellan, C; Hill, H; Jacqz-Aigrain, E; Kassai, B; Kearns, GL; Le Guellec, C; Mahoney, S; Neal, T; Paulus, S; Turner, MA; van den Anker, JN; Zhao, W, 2014) |
| "ciprofloxacin was at least equivalent to imipenem in terms of bacteriological eradication and clinical response." | 2.69 | Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. ( Caldwell, JW; Johnson, RH; Singh, S, 1999) |
| " The mean bioavailability of enteral dosing was 53." | 2.69 | Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections. ( Bruining, HA; Buijk, SL; de Marie, S; Kluytmans, JA; Mouton, JW; van Vliet, A; VandenBergh, MF, 1998) |
| " Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn." | 2.67 | Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994) |
| "Ciprofloxacin/metronidazole was more cost-effective compared with piperacillin/tazobactam (2200 US dollars-3600 US dollars lower cost-effective ratios per patient) regardless of whether the patient had a diagnosis of appendicitis or whether a switch to an oral drug was permissible." | 2.42 | Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections. ( Madan, AK, 2004) |
| "We report a case of Eikenella discitis occurring soon after spinal surgery in an otherwise healthy patient, review the literature on bone and joint infections unrelated to human bites and fist-fight injuries, and stress the importance of definitive diagnosis in post-operative spinal infections." | 2.41 | Eikenella corrodens discitis after spinal surgery: case report and literature review. ( Ang, BS; Ngan, CC, 2002) |
| "Ciprofloxacin was the most prescribed oral antibiotic (53%)." | 1.72 | Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure. ( Gross, AE; Nakaranurack, C; Pradubkham, T; Suwanpimolkul, G, 2022) |
| "Plague is a life-threatening disease caused by the bacterium, Yersinia pestis." | 1.48 | Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. ( Andrianaivoarimanana, V; Bertherat, E; Rajaonarison, R; Rajerison, M; Rakotondramaro, T; Rogier, C, 2018) |
| " Ciprofloxacin dosed in identical fashion displayed rapid clearance with a half-life of approximately 30 min." | 1.48 | Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. ( Chen, J; Convertine, AJ; Lee, B; Ratner, DM; Skerrett, SJ; Srinivasan, S; Stayton, PS; Su, FY; West, TE, 2018) |
| "Ciprofloxacin treatment exhibited an independent protective effect (adjusted hazard ratio (aHR) 0." | 1.40 | Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. ( Ariza, J; Bahamonde, A; Baraia-Etxaburu, JM; Benito, N; Cobo, J; Corona, PS; del Toro, MD; Euba, G; Fernández-Sampedro, M; Flores-Sánchez, X; Guio, L; Iribarren, JA; Lora-Tamayo, J; Palomino, J; Pigrau, C; Ramos, A; Riera, M; Rodríguez-Pardo, D; Sánchez-Somolinos, M; Soriano, A; Sorli, L, 2014) |
| "We present a unique case of acute bacterial prostatitis caused by a very rare human pathogen, Raoultella planticola, in a renal allograft recipient 3." | 1.40 | Acute prostatitis caused by Raoultella planticola in a renal transplant recipient: a novel case. ( Bakalis, A; Belesiotou, E; Drakopoulos, S; Kalatzis, V; Koukoulaki, M; Papastamopoulos, V; Skoutelis, A, 2014) |
| "Linezolid was selected as a first-line antimicrobial drug." | 1.39 | Otogenic cerebellar abscess by Enterococcus avium, a very rare infectious agent. ( Escribano, JA; Lozano, J; Rivin, E; Solivera, J; Vidal, E, 2013) |
| "We report a case of surgical site infection with ciprofloxacin-resistant Aeromonas hydrophila following leech therapy." | 1.39 | Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. ( Bobenchik, AM; Deville, JG; Giltner, CL; Humphries, RM; Uslan, DZ, 2013) |
| "Gatifloxacin showed lower resistance levels than moxifloxacin." | 1.38 | [In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012) |
| "A population pharmacokinetic model was first developed on ciprofloxacin serum concentrations obtained in 102 ICU patients." | 1.37 | Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. ( Conil, JM; Georges, B; Houin, G; Khachman, D; Laffont, CM; Saivin, S; Toutain, PL, 2011) |
| "Paronychia is a well-known, but difficult to treat cutaneous toxicity associated with epidermal growth factor receptor (EGFR) inhibitor therapy." | 1.36 | Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. ( Eames, T; Grabein, B; Kroth, J; Wollenberg, A, 2010) |
| "Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD)." | 1.36 | Quinolone-resistant Aeromonas hydrophila peritonitis in a CAPD patient. ( Barut, HS; Sahin, I, 2010) |
| "Ertapenem and imipenem were the most active drugs tested, inhibiting over 90% of all species, including ESBL-positive isolates with the exception of Pseudomonas aeruginosa isolates (<90% susceptible to all study drugs) and ESBL-positive Klebsiella pneumoniae isolates (<90% susceptible to all study drugs except imipenem)." | 1.35 | Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. ( Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL, 2009) |
| "Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication." | 1.35 | Fluoroquinolone resistance during 2000-2005: an observational study. ( Lindsell, C; Ryan, RJ; Sheehan, P, 2008) |
| "Ciprofloxacin-untreated rats exhibited a predominantly gram-negative polymicrobial sepsis." | 1.34 | Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis. ( Fareed, J; Florian-Kujawski, M; Goto, M; Hammadeh, R; Hoppensteadt, D; Iqbal, O; Ravindranath, TM; Sayeed, MM, 2007) |
| "An 81-year-old man developed septic arthritis and bacteraemia with Aeromonas veronii biovar sobria." | 1.33 | Aeromonas veronii biovar sobria bacteraemia with septic arthritis confirmed by 16S rDNA PCR in an immunocompetent adult. ( Enoch, DA; Harris, KA; Karas, JA; Roberts, MTM, 2006) |
| " Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic." | 1.33 | Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. ( Bedenic, B; Bubonja, M; Budimir, A; Topic, M, 2006) |
| "Ciprofloxacin resistance was more frequent in children who shared an environment with adults who were receiving ciprofloxacin prophylaxis." | 1.33 | Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. ( Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM, 2005) |
| " pneumoniae, MPC results were below susceptible breakpoints and within clinically achievable and sustainable drug concentrations for >24 hours of the dosing interval against." | 1.33 | Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. ( Blondeau, JM; Hansen, GT, 2005) |
| "Severe thrombocytopenia is a life-threatening condition." | 1.32 | Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. ( Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE, 2004) |
| "A patient with chronic lymphocytic leukemia developed a cutaneous infection with the clinical pattern of necrotizing otitis externa." | 1.32 | [Necrotizing otitis externa caused by Stenotrophomonas maltophilia]. ( Börner, D; Fischer, M; Marsch, WC, 2003) |
| "Rhinoscleroma is a very rare cause of upper airway obstruction with only isolated reports in the literature of rhinoscleroma with isolated tracheal obstruction." | 1.31 | Upper airway obstruction due to rhinoscleroma: case report. ( Al Jahdali, H; Al Othman, A; Al-Zuwayed, M; Bamefleh, H; Memish, Z, 2001) |
| "Ciprofloxacin was also tested against Gram-negative isolates." | 1.31 | Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. ( Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL, 2002) |
| "Ciprofloxacin was the most potent study drug against the family of Enterobacteriaceae and Pseudomonas spp." | 1.30 | Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests. ( Barry, AL; Brown, SD; Fuchs, PC, 1999) |
| "Moxifloxacin was eight- to 32-fold more potent than ciprofloxacin and ofloxacin against staphylococci and Streptococcus pneumoniae, and equivalent to eight-fold more potent against enterococci." | 1.30 | Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. ( Chartrand, SA; Moland, ES; Pong, A; Sanders, CC; Thomson, KS, 1999) |
| "Neutropenia was less severe (P < 0." | 1.29 | Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats. ( Bruggeman, CA; Stals, FS; vd Bogaard, AE, 1994) |
| "Amikacin and imipenem were the agents most active against the 33,869 nonduplicate isolates (those recovered only once) tested." | 1.29 | Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. ( Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA, 1996) |
| " Given the disparity among various in vitro susceptibility methods, this study incorporated a unique pharmacodynamic model to more accurately characterize the bacterial time-kill curves and mutation rates of four clinical isolates of S." | 1.29 | Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. ( Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA, 1996) |
| "Ciprofloxacin was administered intravenously to six ponies at a dose of 5 mg per kg body weight." | 1.29 | Pharmacokinetics of ciprofloxacin in ponies. ( Dowling, PM; Duran, SH; Tyler, JW; Wilson, RC, 1995) |
| "Treatment with ciprofloxacin appeared to accelerate recovery from severe or persistent diarrhoea due to this organism." | 1.28 | Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin. ( Harvey, G; Laing, RB; Nathwani, D; Smith, CC, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 53 (22.94) | 18.2507 |
| 2000's | 81 (35.06) | 29.6817 |
| 2010's | 87 (37.66) | 24.3611 |
| 2020's | 10 (4.33) | 2.80 |
| Authors | Studies |
|---|---|
| Morio, F | 1 |
| Jean-Pierre, H | 1 |
| Dubreuil, L | 1 |
| Jumas-Bilak, E | 1 |
| Calvet, L | 1 |
| Mercier, G | 1 |
| Devine, R | 1 |
| Marchandin, H | 1 |
| Zhanel, GG | 1 |
| DeCorby, M | 1 |
| Laing, N | 1 |
| Weshnoweski, B | 1 |
| Vashisht, R | 1 |
| Tailor, F | 1 |
| Nichol, KA | 1 |
| Wierzbowski, A | 1 |
| Baudry, PJ | 1 |
| Karlowsky, JA | 1 |
| Lagacé-Wiens, P | 1 |
| Walkty, A | 1 |
| McCracken, M | 1 |
| Mulvey, MR | 1 |
| Johnson, J | 1 |
| Hoban, DJ | 2 |
| Liu, CY | 1 |
| Huang, YT | 1 |
| Liao, CH | 1 |
| Hsueh, PR | 4 |
| Sánchez-Céspedes, J | 1 |
| Blasco, MD | 1 |
| Marti, S | 1 |
| Alba, V | 1 |
| Alcalde, E | 1 |
| Esteve, C | 1 |
| Vila, J | 1 |
| Amsler, KM | 1 |
| Davies, TA | 1 |
| Shang, W | 1 |
| Jacobs, MR | 1 |
| Bush, K | 1 |
| Shimizu, K | 1 |
| Kikuchi, K | 1 |
| Sasaki, T | 1 |
| Takahashi, N | 1 |
| Ohtsuka, M | 1 |
| Ono, Y | 1 |
| Hiramatsu, K | 1 |
| Rossolini, GM | 1 |
| Luzzaro, F | 1 |
| Migliavacca, R | 1 |
| Mugnaioli, C | 1 |
| Pini, B | 1 |
| De Luca, F | 1 |
| Perilli, M | 1 |
| Pollini, S | 1 |
| Spalla, M | 1 |
| Amicosante, G | 1 |
| Toniolo, A | 1 |
| Pagani, L | 1 |
| Hawser, SP | 1 |
| Bouchillon, SK | 1 |
| Badal, RE | 1 |
| Paterson, DL | 2 |
| Hsu, LY | 1 |
| Tan, TY | 1 |
| Tam, VH | 1 |
| Kwa, A | 1 |
| Fisher, DA | 1 |
| Koh, TH | 1 |
| Makawana, JA | 1 |
| Mungra, DC | 1 |
| Patel, MP | 1 |
| Patel, RG | 1 |
| Montgomery, JI | 1 |
| Brown, MF | 1 |
| Reilly, U | 1 |
| Price, LM | 1 |
| Abramite, JA | 1 |
| Arcari, J | 1 |
| Barham, R | 1 |
| Che, Y | 1 |
| Chen, JM | 1 |
| Chung, SW | 1 |
| Collantes, EM | 1 |
| Desbonnet, C | 1 |
| Doroski, M | 1 |
| Doty, J | 1 |
| Engtrakul, JJ | 1 |
| Harris, TM | 1 |
| Huband, M | 1 |
| Knafels, JD | 1 |
| Leach, KL | 1 |
| Liu, S | 1 |
| Marfat, A | 1 |
| McAllister, L | 1 |
| McElroy, E | 1 |
| Menard, CA | 1 |
| Mitton-Fry, M | 1 |
| Mullins, L | 1 |
| Noe, MC | 1 |
| O'Donnell, J | 1 |
| Oliver, R | 1 |
| Penzien, J | 1 |
| Plummer, M | 1 |
| Shanmugasundaram, V | 1 |
| Thoma, C | 1 |
| Tomaras, AP | 1 |
| Uccello, DP | 1 |
| Vaz, A | 1 |
| Wishka, DG | 1 |
| Mohammed, JM | 1 |
| Sajana, TM | 1 |
| Raj, R | 1 |
| Rachana, BA | 1 |
| Paul, G | 1 |
| Pillai, PR | 1 |
| Li, LH | 1 |
| Lu, HF | 1 |
| Liu, YF | 1 |
| Lin, YT | 1 |
| Yang, TC | 1 |
| Pradubkham, T | 1 |
| Suwanpimolkul, G | 1 |
| Gross, AE | 1 |
| Nakaranurack, C | 1 |
| Chatree, Y | 1 |
| Charoenlap, N | 1 |
| Vanitshavit, V | 1 |
| Ruangrassamee, P | 1 |
| Mongkolsuk, S | 1 |
| Vattanaviboon, P | 1 |
| Yu, S | 1 |
| Wang, S | 1 |
| Zou, P | 1 |
| Chai, G | 1 |
| Lin, YW | 1 |
| Velkov, T | 1 |
| Li, J | 1 |
| Pan, W | 1 |
| Zhou, QT | 1 |
| Dilhari, A | 1 |
| Pathirage, S | 1 |
| Gunasekara, C | 1 |
| Fernando, N | 1 |
| Weerasekara, D | 1 |
| McBain, A | 1 |
| Weerasekera, M | 1 |
| Valéry, M | 1 |
| Bourrel, AS | 1 |
| Grignano, E | 1 |
| Kernéis, S | 1 |
| Contejean, A | 1 |
| Siebert, C | 1 |
| Villers, C | 1 |
| Pavlou, G | 1 |
| Touquet, B | 1 |
| Yakandawala, N | 1 |
| Tardieux, I | 1 |
| Renesto, P | 1 |
| Hao, Y | 1 |
| Chen, S | 1 |
| Chang, H | 1 |
| Yan, X | 1 |
| Zhou, W | 1 |
| Cao, X | 1 |
| Huang, R | 1 |
| Zhang, Z | 1 |
| Zhang, H | 1 |
| Jia, B | 1 |
| Wu, W | 1 |
| Xiong, Y | 1 |
| Chen, Y | 2 |
| Wu, C | 2 |
| Vidal-Veuthey, B | 1 |
| Jara, R | 1 |
| Santander, K | 1 |
| Mella, A | 1 |
| Ruiz, S | 1 |
| Collado, L | 1 |
| Miyamoto, Y | 1 |
| Udaka, K | 1 |
| Sekimoto, E | 1 |
| Shibata, H | 1 |
| Otsuka, K | 1 |
| Mori, K | 1 |
| Shigekiyo, T | 1 |
| Ozaki, S | 1 |
| Wattier, RL | 1 |
| Levy, ER | 1 |
| Sabnis, AJ | 1 |
| Dvorak, CC | 1 |
| Auerbach, AD | 1 |
| Matsuura, N | 1 |
| Miyoshi, M | 1 |
| Doi, N | 1 |
| Yagi, S | 1 |
| Aradono, E | 1 |
| Imamura, T | 1 |
| Koga, R | 1 |
| Chang, J | 1 |
| Xu, Z | 1 |
| Wang, Z | 2 |
| Zeng, Q | 1 |
| Fan, H | 1 |
| Varo, R | 1 |
| Sitoe, A | 1 |
| Cossa, A | 1 |
| Ordi, J | 1 |
| Rozman, M | 1 |
| Bassat, Q | 1 |
| Palioura, S | 1 |
| Gibbons, A | 1 |
| Miller, D | 2 |
| OʼBrien, TP | 1 |
| Alfonso, EC | 2 |
| Spierer, O | 1 |
| Bianco, G | 1 |
| Boattini, M | 1 |
| Audisio, E | 1 |
| Cavallo, R | 1 |
| Costa, C | 1 |
| Hamed, SM | 1 |
| Aboshanab, KMA | 1 |
| El-Mahallawy, HA | 1 |
| Helmy, MM | 1 |
| Ashour, MS | 1 |
| Elkhatib, WF | 1 |
| Frawley, AA | 1 |
| Powell, L | 1 |
| McQuiston, JR | 1 |
| Gulvik, CA | 1 |
| Bégué, RE | 1 |
| Poore, TS | 1 |
| Virella-Lowell, I | 1 |
| Guimbellot, JS | 1 |
| Andrianaivoarimanana, V | 1 |
| Bertherat, E | 1 |
| Rajaonarison, R | 1 |
| Rakotondramaro, T | 1 |
| Rogier, C | 1 |
| Rajerison, M | 1 |
| Su, FY | 1 |
| Srinivasan, S | 1 |
| Lee, B | 1 |
| Chen, J | 1 |
| Convertine, AJ | 1 |
| West, TE | 1 |
| Ratner, DM | 1 |
| Skerrett, SJ | 1 |
| Stayton, PS | 1 |
| Zavrelova, A | 1 |
| Paterova, P | 1 |
| Gabalec, F | 1 |
| Zak, P | 1 |
| Radocha, J | 1 |
| Villaverde González, S | 1 |
| Eugenieva Marinova, F | 1 |
| Rasines Rodríguez, A | 1 |
| Orden Martínez, B | 1 |
| Golmayo Gaztelu, L | 1 |
| Saez Nieto, JA | 1 |
| Cilleruelo Ortega, MJ | 1 |
| Tokatly Latzer, I | 1 |
| Nahum, E | 1 |
| Cavari, Y | 1 |
| Lazar, I | 1 |
| Ben-Ari, Y | 1 |
| Ben-Shimol, S | 1 |
| Ben-Shalom, G | 1 |
| Geffen, Y | 1 |
| Goldberg, L | 1 |
| Rubinstein, M | 1 |
| Keller, N | 1 |
| Pessach, IM | 1 |
| Paret, G | 1 |
| Luna, BM | 1 |
| Ershova, K | 1 |
| Yan, J | 1 |
| Ulhaq, A | 1 |
| Nielsen, TB | 1 |
| Hsieh, S | 1 |
| Pantapalangkoor, P | 1 |
| Vanscoy, B | 1 |
| Ambrose, P | 1 |
| Rudin, S | 1 |
| Hujer, K | 1 |
| Bonomo, RA | 1 |
| Actis, L | 1 |
| Skaar, EP | 1 |
| Spellberg, B | 1 |
| Wilmer, A | 1 |
| Slater, K | 1 |
| Yip, J | 1 |
| Carr, N | 1 |
| Grant, J | 1 |
| Escribano, JA | 1 |
| Solivera, J | 1 |
| Vidal, E | 1 |
| Rivin, E | 1 |
| Lozano, J | 1 |
| Dabkowski, J | 1 |
| Dodds, P | 1 |
| Hughes, K | 1 |
| Bush, M | 1 |
| Graham, SM | 1 |
| Fishlock, A | 1 |
| Millner, P | 1 |
| Sandoe, J | 1 |
| Pence, MA | 1 |
| Sharon, J | 1 |
| McElvania Tekippe, E | 1 |
| Pakalniskis, BL | 1 |
| Ford, BA | 1 |
| Burnham, CA | 1 |
| Fatima, A | 1 |
| Afridi, FI | 1 |
| Qureshi, A | 1 |
| Farooqi, BJ | 1 |
| Hussain, A | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| van Alphen, NA | 1 |
| Gonzalez, A | 1 |
| McKenna, MC | 1 |
| McKenna, TK | 1 |
| Carlsen, BT | 1 |
| Moran, SL | 1 |
| Dobiasova, H | 1 |
| Kutilova, I | 1 |
| Piackova, V | 1 |
| Vesely, T | 1 |
| Cizek, A | 1 |
| Dolejska, M | 1 |
| Koukoulaki, M | 1 |
| Bakalis, A | 1 |
| Kalatzis, V | 1 |
| Belesiotou, E | 1 |
| Papastamopoulos, V | 1 |
| Skoutelis, A | 2 |
| Drakopoulos, S | 1 |
| Rodríguez-Pardo, D | 1 |
| Pigrau, C | 1 |
| Lora-Tamayo, J | 1 |
| Soriano, A | 1 |
| del Toro, MD | 1 |
| Cobo, J | 1 |
| Palomino, J | 1 |
| Euba, G | 1 |
| Riera, M | 1 |
| Sánchez-Somolinos, M | 1 |
| Benito, N | 1 |
| Fernández-Sampedro, M | 1 |
| Sorli, L | 1 |
| Guio, L | 1 |
| Iribarren, JA | 1 |
| Baraia-Etxaburu, JM | 1 |
| Ramos, A | 1 |
| Bahamonde, A | 1 |
| Flores-Sánchez, X | 1 |
| Corona, PS | 1 |
| Ariza, J | 1 |
| Zhao, W | 1 |
| Hill, H | 1 |
| Le Guellec, C | 1 |
| Neal, T | 1 |
| Mahoney, S | 1 |
| Paulus, S | 1 |
| Castellan, C | 1 |
| Kassai, B | 1 |
| van den Anker, JN | 1 |
| Kearns, GL | 1 |
| Turner, MA | 1 |
| Jacqz-Aigrain, E | 1 |
| Wong, PH | 1 |
| von Krosigk, M | 1 |
| Roscoe, DL | 1 |
| Lau, TT | 1 |
| Yousefi, M | 1 |
| Bowie, WR | 1 |
| Ochieng', N | 1 |
| Okechi, H | 1 |
| Ferson, S | 1 |
| Albright, AL | 1 |
| Sand, D | 1 |
| She, R | 1 |
| Shulman, IA | 1 |
| Chen, DS | 1 |
| Schur, M | 1 |
| Hsu, HY | 1 |
| Li, L | 1 |
| Tarrand, JJ | 1 |
| Han, XY | 1 |
| Guo, W | 1 |
| He, Q | 1 |
| Wei, M | 1 |
| Yang, Z | 1 |
| Du, Y | 1 |
| He, J | 1 |
| Card, RM | 1 |
| Mafura, M | 1 |
| Hunt, T | 1 |
| Kirchner, M | 1 |
| Weile, J | 1 |
| Rashid, MU | 1 |
| Weintraub, A | 1 |
| Nord, CE | 1 |
| Anjum, MF | 1 |
| Calzada, M | 1 |
| Roig, M | 1 |
| Martínez-Toldos, MC | 1 |
| Segovia, M | 1 |
| Shirzad Aski, H | 1 |
| Tabatabaei, M | 1 |
| Khoshbakht, R | 1 |
| Raeisi, M | 1 |
| Decroix, V | 1 |
| Pluquet, E | 1 |
| Choquet, M | 1 |
| Ammenouche, N | 1 |
| Castelain, S | 1 |
| Guiheneuf, R | 1 |
| Chanyi, RM | 1 |
| Koval, SF | 1 |
| Brooke, JS | 1 |
| Rajchgot, J | 1 |
| Glicksman, R | 1 |
| Bogoch, II | 1 |
| Morganti, L | 1 |
| Córdova, E | 1 |
| Cassini, E | 1 |
| Gómez, N | 1 |
| López Moral, L | 1 |
| Badía, M | 1 |
| Rodríguez, C | 1 |
| Langford, BJ | 1 |
| Seah, J | 1 |
| Chan, A | 1 |
| Downing, M | 1 |
| Johnstone, J | 1 |
| Matukas, LM | 1 |
| Usarek, P | 1 |
| Dobrzaniecka, K | 1 |
| Szymanek-Majchrzak, K | 1 |
| Sawicka-Grzelak, A | 1 |
| Mlynarczyk, A | 1 |
| Durlik, M | 1 |
| Ciszek, M | 1 |
| Paczek, L | 1 |
| Chmura, A | 1 |
| Kwiatkowski, A | 1 |
| Mlynarczyk, G | 1 |
| Margaritis, A | 1 |
| Galani, I | 1 |
| Chatzikonstantinou, M | 1 |
| Petrikkos, G | 1 |
| Souli, M | 1 |
| Olszewski, AE | 1 |
| Karandikar, MV | 1 |
| Surana, NK | 1 |
| Ullah, O | 1 |
| Khan, A | 1 |
| Ambreen, A | 1 |
| Ahmad, I | 1 |
| Akhtar, T | 1 |
| Gandapor, AJ | 1 |
| Khan, AM | 1 |
| Al Omar, S | 1 |
| Anabtawi, N | 1 |
| Al Qasem, W | 1 |
| Rihani, R | 1 |
| Domosławska, A | 1 |
| Zduńczyk, S | 1 |
| Jurczak, A | 1 |
| Janowski, T | 1 |
| Nazik, H | 1 |
| Ongen, B | 1 |
| Kuvat, N | 1 |
| Reddy, AK | 1 |
| Murthy, SI | 1 |
| Jalali, S | 1 |
| Gopinathan, U | 1 |
| Aubert, T | 1 |
| Rovery, C | 1 |
| Bourhaba, K | 1 |
| Singeorzan, S | 1 |
| Heim, M | 1 |
| Crétel, E | 1 |
| Battaglia, TC | 1 |
| Lim, IW | 1 |
| Stride, PJ | 1 |
| Horvath, RL | 1 |
| Hamilton-Craig, CR | 1 |
| Chau, PP | 1 |
| Passerini de Rossi, B | 1 |
| García, C | 1 |
| Calenda, M | 1 |
| Vay, C | 2 |
| Franco, M | 1 |
| Bourdais, L | 1 |
| Heusse, JL | 1 |
| Aillet, S | 1 |
| Schoentgen, C | 1 |
| Watier, E | 1 |
| Pearson, RN | 1 |
| Kaya, O | 2 |
| Ozdemir, F | 1 |
| Atli, M | 1 |
| Aslan, V | 1 |
| Cağatay, M | 1 |
| Anlar, M | 1 |
| Alper, M | 1 |
| Oostdijk, EA | 1 |
| de Smet, AM | 1 |
| Blok, HE | 1 |
| Thieme Groen, ES | 1 |
| van Asselt, GJ | 1 |
| Benus, RF | 1 |
| Bernards, SA | 1 |
| Frénay, IH | 1 |
| Jansz, AR | 1 |
| de Jongh, BM | 1 |
| Kaan, JA | 1 |
| Leverstein-van Hall, MA | 1 |
| Mascini, EM | 1 |
| Pauw, W | 1 |
| Sturm, PD | 1 |
| Thijsen, SF | 1 |
| Kluytmans, JA | 2 |
| Bonten, MJ | 1 |
| Eames, T | 1 |
| Grabein, B | 1 |
| Kroth, J | 1 |
| Wollenberg, A | 1 |
| Khassawneh, M | 1 |
| Hayajneh, W | 1 |
| Sahin, I | 1 |
| Barut, HS | 1 |
| Thabet, L | 1 |
| Memmi, M | 1 |
| Turki, A | 1 |
| Messadi, AA | 1 |
| Gaitán, JI | 1 |
| Bronze, MS | 1 |
| Akhtar, N | 1 |
| Alqurashi, AM | 1 |
| Abu Twibah, M | 1 |
| Quintela Obregón, E | 1 |
| Palomar Fontanet, R | 1 |
| Salas, C | 1 |
| Rodrigo Calabia, E | 1 |
| Arias Rodríguez, M | 1 |
| Ouyang-Latimer, J | 1 |
| Jafri, S | 1 |
| VanTassel, A | 1 |
| Jiang, ZD | 1 |
| Gurleen, K | 1 |
| Rodriguez, S | 1 |
| Nandy, RK | 1 |
| Ramamurthy, T | 2 |
| Chatterjee, S | 1 |
| McKenzie, R | 1 |
| Steffen, R | 1 |
| DuPont, HL | 1 |
| Lin, HC | 1 |
| Ma, DH | 1 |
| Chen, YF | 1 |
| Yeh, LK | 1 |
| Hsiao, CH | 1 |
| Wang, EW | 1 |
| Warren, DK | 1 |
| Ferris, VM | 1 |
| Casabar, E | 1 |
| Nussenbaum, B | 1 |
| Dommeti, P | 1 |
| Wang, L | 1 |
| Flannery, EL | 1 |
| Symons, K | 1 |
| Mody, L | 1 |
| Yang, CH | 1 |
| Tsui, TL | 1 |
| Tsao, SM | 1 |
| Liu, KS | 1 |
| Chen, TY | 1 |
| Wang, YL | 1 |
| Teng, YH | 1 |
| Lee, YT | 1 |
| Khachman, D | 1 |
| Conil, JM | 1 |
| Georges, B | 1 |
| Saivin, S | 1 |
| Houin, G | 1 |
| Toutain, PL | 1 |
| Laffont, CM | 1 |
| Troughton, JA | 1 |
| Millar, G | 1 |
| Smyth, ET | 1 |
| Doherty, L | 1 |
| McMullan, R | 1 |
| Scheetz, MH | 1 |
| Bolon, MK | 1 |
| Esterly, JS | 1 |
| Reddy, P | 1 |
| Postelnick, M | 1 |
| Lee, TA | 1 |
| Al-Hamad, A | 1 |
| Burnie, J | 1 |
| Upton, M | 1 |
| Cho, HH | 1 |
| Sung, JY | 1 |
| Kwon, KC | 1 |
| Koo, SH | 1 |
| Burd, EM | 1 |
| Sharp, SE | 1 |
| Medina Presentado, JC | 1 |
| Paciel López, D | 1 |
| Berro Castiglioni, M | 1 |
| Gerez, J | 1 |
| Issaoui, S | 1 |
| Maoulainine, FM | 1 |
| Elidrissi, NS | 1 |
| Sorra, N | 1 |
| Chabaa, L | 1 |
| Aboussad, A | 1 |
| Durdu, B | 1 |
| Durdu, Y | 1 |
| Güleç, N | 1 |
| Islim, F | 1 |
| Biçer, M | 1 |
| Wong, CA | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Villareal, D | 1 |
| Rey, JJ | 1 |
| Olajide, TG | 1 |
| Fadeyi, A | 1 |
| Segun-Busari, S | 1 |
| Mandisodza, O | 1 |
| Burrows, E | 1 |
| Nulsen, M | 1 |
| Samonis, G | 1 |
| Karageorgopoulos, DE | 1 |
| Maraki, S | 1 |
| Levis, P | 1 |
| Dimopoulou, D | 1 |
| Spernovasilis, NA | 1 |
| Kofteridis, DP | 1 |
| Falagas, ME | 1 |
| Hewer, SL | 1 |
| Tsai, SF | 1 |
| Chen, CH | 1 |
| Shu, KH | 1 |
| Wu, MJ | 1 |
| Coutinho, AS | 1 |
| de Morais, OO | 1 |
| Gomes, CM | 1 |
| de Oliveira Carneiro da Motta, J | 1 |
| Patel, KM | 1 |
| Svestka, M | 1 |
| Sinkin, J | 1 |
| Ruff, P | 1 |
| Gould, VC | 1 |
| Okazaki, A | 1 |
| Avison, MB | 1 |
| Ogbolu, DO | 1 |
| Terry-Alli, OA | 1 |
| Daini, OA | 1 |
| Olabiyi, FA | 1 |
| Igharo, EA | 1 |
| Giltner, CL | 1 |
| Bobenchik, AM | 1 |
| Uslan, DZ | 1 |
| Deville, JG | 1 |
| Humphries, RM | 1 |
| Chong, Y | 1 |
| Shimoda, S | 1 |
| Yakushiji, H | 1 |
| Ito, Y | 1 |
| Miyamoto, T | 1 |
| Kamimura, T | 1 |
| Shimono, N | 1 |
| Akashi, K | 1 |
| Schelenz, S | 1 |
| Nwaka, D | 1 |
| Hunter, PR | 1 |
| Venkata, N | 1 |
| Sharma, S | 1 |
| Gora, R | 1 |
| Chhabra, R | 1 |
| Aasuri, MK | 1 |
| Higgins, PG | 1 |
| Fluit, AC | 1 |
| Hafner, D | 1 |
| Verhoef, J | 1 |
| Schmitz, FJ | 1 |
| Ang, BS | 1 |
| Ngan, CC | 1 |
| Lo, WT | 1 |
| Wang, CC | 1 |
| Lee, CM | 1 |
| Chu, ML | 1 |
| Neuhauser, MM | 1 |
| Weinstein, RA | 2 |
| Rydman, R | 1 |
| Danziger, LH | 1 |
| Karam, G | 1 |
| Quinn, JP | 2 |
| Rodríguez, CH | 1 |
| Juárez, J | 1 |
| de Mier, C | 1 |
| Pugliese, L | 1 |
| Blanco, G | 1 |
| Famiglietti, A | 1 |
| Holden, BA | 1 |
| Sweeney, DF | 1 |
| Sankaridurg, PR | 1 |
| Carnt, N | 1 |
| Edwards, K | 1 |
| Stretton, S | 1 |
| Stapleton, F | 1 |
| Ko, WC | 1 |
| Chiang, SR | 1 |
| Lee, HC | 1 |
| Tang, HJ | 1 |
| Wang, YY | 1 |
| Chuang, YC | 1 |
| Kirkan, S | 1 |
| Göksoy, EO | 1 |
| Börner, D | 1 |
| Marsch, WC | 1 |
| Fischer, M | 1 |
| Mitchell, AE | 1 |
| Derrington, P | 1 |
| Turner, P | 1 |
| Hunt, LP | 1 |
| Oakhill, A | 1 |
| Marks, DI | 1 |
| Rösch, T | 1 |
| Triptrap, A | 1 |
| Born, P | 1 |
| Ott, R | 1 |
| Weigert, N | 1 |
| Frimberger, E | 1 |
| Allescher, HD | 1 |
| Classen, M | 1 |
| Kamereck, K | 1 |
| Waugh, J | 1 |
| Keating, GM | 1 |
| Isenmann, R | 1 |
| Rünzi, M | 1 |
| Kron, M | 1 |
| Kahl, S | 1 |
| Kraus, D | 1 |
| Jung, N | 1 |
| Maier, L | 1 |
| Malfertheiner, P | 1 |
| Goebell, H | 1 |
| Beger, HG | 1 |
| Gogos, CA | 1 |
| Lekkou, A | 1 |
| Drosou, E | 1 |
| Starakis, I | 1 |
| Marangos, MN | 1 |
| Bassaris, HP | 1 |
| Arnold, DM | 1 |
| Smaill, F | 1 |
| Warkentin, TE | 1 |
| Christjanson, L | 1 |
| Walker, I | 1 |
| Sinha, S | 1 |
| Chattopadhyay, S | 1 |
| Bhattacharya, SK | 1 |
| Nair, GB | 1 |
| Madan, AK | 1 |
| Okimoto, N | 1 |
| Yamato, K | 1 |
| Honda, Y | 1 |
| Kurihara, T | 1 |
| Osaki, K | 1 |
| Asaoka, N | 1 |
| Fujita, K | 1 |
| Ohba, H | 1 |
| McKnight, AJ | 1 |
| Shaw, A | 1 |
| Goldsmith, CE | 1 |
| Clarke, L | 1 |
| Millar, BC | 1 |
| McCaughan, J | 1 |
| Elborn, JS | 1 |
| Reid, A | 1 |
| Moore, JE | 1 |
| Castagnola, E | 1 |
| Haupt, R | 1 |
| Micozzi, A | 1 |
| Caviglia, I | 1 |
| Testi, AM | 1 |
| Giona, F | 1 |
| Parodi, S | 1 |
| Girmenia, C | 1 |
| Hansen, GT | 1 |
| Blondeau, JM | 1 |
| Roberts, MTM | 1 |
| Enoch, DA | 1 |
| Harris, KA | 1 |
| Karas, JA | 1 |
| Beno, P | 1 |
| Krcmery, V | 1 |
| Demitrovicova, A | 1 |
| Hassoun, A | 1 |
| Eiland, E | 1 |
| Minaeva, NZ | 1 |
| Minaev, VI | 1 |
| Sokolov, AA | 1 |
| Avilova, ND | 1 |
| Mitrokhin, SD | 1 |
| Yilmaz, G | 1 |
| Aydin, K | 1 |
| Koksal, I | 1 |
| Caylan, R | 1 |
| Akcay, K | 1 |
| Arslan, M | 1 |
| Legout, L | 1 |
| Senneville, E | 1 |
| Stern, R | 1 |
| Yazdanpanah, Y | 1 |
| Savage, C | 1 |
| Roussel-Delvalez, M | 1 |
| Rosele, B | 1 |
| Migaud, H | 1 |
| Mouton, Y | 1 |
| Bedenic, B | 1 |
| Topic, M | 1 |
| Budimir, A | 1 |
| Bubonja, M | 1 |
| Jones, SL | 1 |
| Nguyen, VK | 1 |
| Nguyen, TM | 1 |
| Athan, E | 1 |
| Metan, G | 1 |
| Alp, E | 1 |
| Aygen, B | 1 |
| Sumerkan, B | 1 |
| Lindbäck, E | 1 |
| Unemo, M | 1 |
| Akhras, M | 1 |
| Gharizadeh, B | 1 |
| Fredlund, H | 1 |
| Pourmand, N | 1 |
| Wretlind, B | 1 |
| Levin, PD | 1 |
| Fowler, RA | 1 |
| Guest, C | 1 |
| Sibbald, WJ | 1 |
| Kiss, A | 1 |
| Simor, AE | 1 |
| Abdelbaqi, K | 1 |
| Ménard, A | 1 |
| Prouzet-Mauleon, V | 1 |
| Bringaud, F | 1 |
| Lehours, P | 1 |
| Mégraud, F | 1 |
| Noviello, S | 1 |
| Ianniello, F | 1 |
| Leone, S | 1 |
| Esposito, S | 1 |
| Uckan, D | 1 |
| Kirazli, S | 1 |
| Gür, D | 2 |
| Tavil, B | 1 |
| Sayinalp, N | 1 |
| Akyüz, C | 1 |
| Yinusa, W | 1 |
| Onche, II | 1 |
| Thanni, LO | 1 |
| Bennett, KM | 1 |
| Scarborough, JE | 1 |
| Sharpe, M | 1 |
| Dodds-Ashley, E | 1 |
| Kaye, KS | 1 |
| Hayward, TZ | 1 |
| Vaslef, SN | 1 |
| Ravindranath, TM | 1 |
| Goto, M | 1 |
| Iqbal, O | 1 |
| Florian-Kujawski, M | 1 |
| Hoppensteadt, D | 1 |
| Hammadeh, R | 1 |
| Sayeed, MM | 1 |
| Fareed, J | 1 |
| Furuya, R | 1 |
| Onoye, Y | 1 |
| Kanayama, A | 1 |
| Saika, T | 1 |
| Iyoda, T | 1 |
| Tatewaki, M | 1 |
| Matsuzaki, K | 1 |
| Kobayashi, I | 1 |
| Tanaka, M | 1 |
| Mulholland, A | 1 |
| Yong-Gee, S | 1 |
| Ramos-Esteban, JC | 1 |
| Jeng, BH | 1 |
| Lee, SM | 1 |
| Kim, MK | 1 |
| Lee, JL | 1 |
| Wee, WR | 1 |
| Lee, JH | 1 |
| Espinoza-Gómez, F | 1 |
| Newton-Sánchez, OA | 1 |
| Melnikov, V | 1 |
| Virgen-González, O | 1 |
| Unrau, J | 1 |
| Afshari, NA | 1 |
| Ma, JJ | 1 |
| Duncan, SM | 1 |
| Pineda, R | 1 |
| Starr, CE | 1 |
| Decroos, FC | 1 |
| Johnson, CS | 1 |
| Adelman, RA | 1 |
| Tulsidas, H | 1 |
| Ong, YY | 1 |
| Chan, KC | 1 |
| Ryan, RJ | 1 |
| Lindsell, C | 1 |
| Sheehan, P | 1 |
| Rautelin, H | 1 |
| Hänninen, ML | 1 |
| Sivonen, A | 1 |
| Turunen, U | 1 |
| Valtonen, V | 1 |
| García-Rodríguez, JA | 1 |
| Fresnadillo, MJ | 1 |
| García, MI | 1 |
| García-Sánchez, E | 1 |
| García-Sánchez, JE | 1 |
| Trujillano, I | 1 |
| Datsenko, BM | 1 |
| Tamm, TI | 1 |
| Wang, JX | 1 |
| Liu, YN | 1 |
| Dowling, PM | 1 |
| Wilson, RC | 1 |
| Tyler, JW | 1 |
| Duran, SH | 1 |
| Vogt, K | 1 |
| Klefisch, F | 1 |
| Hahn, H | 1 |
| Schmutzler, H | 1 |
| Fombeur, JP | 1 |
| Barrault, S | 1 |
| Koubbi, G | 1 |
| Laurier, JN | 1 |
| Ebbo, D | 1 |
| Lecomte, F | 1 |
| Sorrel, N | 1 |
| Dobler, S | 1 |
| Beam, TR | 1 |
| Khurana, CM | 1 |
| Wojack, BR | 1 |
| Jones, RN | 1 |
| Marshall, SA | 1 |
| Stals, FS | 1 |
| vd Bogaard, AE | 1 |
| Bruggeman, CA | 1 |
| Newton, JA | 1 |
| Kennedy, CA | 1 |
| Linquist, JA | 1 |
| Riemer, B | 1 |
| Hazelrig, PE | 1 |
| Chayakul, P | 1 |
| Krisanapan, S | 1 |
| Kalnauwakul, S | 1 |
| Belliveau, P | 1 |
| Nightingale, CH | 1 |
| Quintiliani, R | 1 |
| Crowe, H | 1 |
| Gousee, G | 1 |
| Zemelman, R | 1 |
| Bello, H | 1 |
| Dominguez, M | 1 |
| Gonzalez, G | 1 |
| Mella, S | 1 |
| Garcia, A | 1 |
| Louie, TJ | 1 |
| Del Favero, A | 1 |
| Menichetti, F | 1 |
| Pfau, A | 1 |
| Sacks, TG | 1 |
| Murphy, GS | 1 |
| Bodhidatta, L | 1 |
| Echeverria, P | 1 |
| Tansuphaswadikul, S | 1 |
| Hoge, CW | 1 |
| Imlarp, S | 1 |
| Tamura, K | 1 |
| Mirelis, B | 1 |
| Miro, E | 1 |
| Navarro, F | 1 |
| Ogalla, CA | 1 |
| Bonal, J | 1 |
| Prats, G | 1 |
| Green, SD | 1 |
| Ilunga, F | 1 |
| Cheesbrough, JS | 1 |
| Tillotson, GS | 1 |
| Hichens, M | 1 |
| Felmingham, D | 1 |
| Liu, PY | 1 |
| Lau, YJ | 1 |
| Hu, BS | 1 |
| Shyr, JM | 1 |
| Shi, ZY | 1 |
| Tsai, WS | 1 |
| Lin, YH | 1 |
| Tseng, CY | 1 |
| Funke, G | 1 |
| Rosner, H | 1 |
| Cornelissen, JJ | 1 |
| Rozenberg-Arska, M | 1 |
| Dekker, AW | 1 |
| Wu, JJ | 1 |
| Hsiue, TR | 1 |
| Hsieh, WC | 1 |
| Mohandas, KM | 1 |
| Kelker, R | 1 |
| Braun, M | 1 |
| Jonas, JB | 1 |
| Schönherr, U | 1 |
| Naumann, GO | 1 |
| Bouza, P | 1 |
| García Falcón, T | 1 |
| Pérez Fontán, M | 1 |
| Rodríguez-Carmona, A | 1 |
| López Vázquez, M | 1 |
| Tresancos, C | 1 |
| Valdés, F | 1 |
| Itokazu, GS | 1 |
| Bell-Dixon, C | 1 |
| Kahan, FM | 1 |
| Bonnet, M | 1 |
| Bonnet, E | 1 |
| Alric, L | 1 |
| Goldzack, M | 1 |
| Massip, P | 1 |
| García del Busto Remón, A | 1 |
| Pardo, F | 1 |
| Moreno, R | 1 |
| Galiano, JV | 1 |
| Bloch, KC | 1 |
| Nadarajah, R | 1 |
| Jacobs, R | 1 |
| Berman, AJ | 1 |
| Del Priore, LV | 1 |
| Fischer, CK | 1 |
| Garrison, MW | 1 |
| Anderson, DE | 1 |
| Campbell, DM | 1 |
| Carroll, KC | 1 |
| Malone, CL | 1 |
| Anderson, JD | 1 |
| Hollis, RJ | 1 |
| Pfaller, MA | 1 |
| Murphy, M | 1 |
| Brown, AE | 1 |
| Sepkowitz, KA | 1 |
| Bernard, EM | 1 |
| Kiehn, TE | 1 |
| Armstrong, D | 1 |
| Kollef, MH | 1 |
| Vlasnik, J | 1 |
| Sharpless, L | 1 |
| Pasque, C | 1 |
| Murphy, D | 1 |
| Fraser, V | 1 |
| Nettles, RE | 1 |
| Sexton, DJ | 1 |
| Goffin, E | 1 |
| Pouthier, D | 1 |
| Vandercam, B | 1 |
| Gigi, J | 1 |
| van Ypersele de Strihou, C | 1 |
| Jönsson, I | 1 |
| Monsen, T | 1 |
| Wiström, J | 1 |
| de Marie, S | 1 |
| VandenBergh, MF | 1 |
| Buijk, SL | 1 |
| Bruining, HA | 1 |
| van Vliet, A | 1 |
| Mouton, JW | 1 |
| Ahmed, A | 1 |
| Hafiz, S | 1 |
| Ahmed, QT | 1 |
| Majeed, H | 1 |
| Syed, S | 1 |
| Lee, YL | 1 |
| Cesario, T | 1 |
| McCauley, V | 1 |
| Flionis, L | 1 |
| Pax, A | 1 |
| Thrupp, L | 1 |
| Caldwell, JW | 1 |
| Singh, S | 1 |
| Johnson, RH | 1 |
| Barry, AL | 1 |
| Fuchs, PC | 1 |
| Brown, SD | 1 |
| Pong, A | 1 |
| Thomson, KS | 1 |
| Moland, ES | 1 |
| Chartrand, SA | 1 |
| Sanders, CC | 1 |
| Lu, PL | 1 |
| Hung, CC | 1 |
| Teng, LJ | 1 |
| Jang, TN | 1 |
| Luh, KT | 1 |
| van den Hoven, R | 1 |
| Wagenaar, JA | 1 |
| Walker, RD | 1 |
| Alexandrakis, G | 1 |
| Gruson, D | 1 |
| Hilbert, G | 1 |
| Vargas, F | 1 |
| Valentino, R | 1 |
| Bebear, C | 2 |
| Allery, A | 1 |
| Gbikpi-Benissan, G | 1 |
| Cardinaud, JP | 1 |
| Wilcox, RA | 1 |
| Chin, GK | 1 |
| Segasothy, M | 1 |
| Terg, R | 1 |
| Cobas, S | 1 |
| Fassio, E | 1 |
| Landeira, G | 1 |
| Ríos, B | 1 |
| Vasen, W | 1 |
| Abecasis, R | 1 |
| Ríos, H | 1 |
| Guevara, M | 1 |
| Delarive, P | 1 |
| Baumgartner, JD | 1 |
| Glauser, MP | 1 |
| Cometta, A | 1 |
| Lema, I | 1 |
| Gómez-Torreiro, M | 1 |
| Rodríguez-Ares, MT | 1 |
| Tripodi, MF | 1 |
| Andreana, A | 1 |
| Sarnataro, G | 1 |
| Ragone, E | 1 |
| Adinolfi, LE | 1 |
| Utili, R | 1 |
| Moore, CC | 1 |
| Lane, JE | 1 |
| Stephens, JL | 1 |
| Reid, G | 1 |
| Habash, M | 1 |
| Vachon, D | 1 |
| Denstedt, J | 1 |
| Riddell, J | 1 |
| Beheshti, M | 1 |
| Orlando, R | 1 |
| Mastrullo, L | 1 |
| De Blasi, D | 1 |
| Boffa, ML | 1 |
| Zorzato, G | 1 |
| Miraglia, E | 1 |
| Al Jahdali, H | 1 |
| Bamefleh, H | 1 |
| Memish, Z | 1 |
| Al-Zuwayed, M | 1 |
| Al Othman, A | 1 |
| Tabin, G | 1 |
| Danenhower, C | 1 |
| Reardon, D | 1 |
| Dimmig, J | 1 |
| McCormick, G | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Presi, S | 1 |
| Furlan, F | 1 |
| Lora, L | 1 |
| Benedetti, P | 1 |
| Bonato, M | 1 |
| Erle, G | 1 |
| de Lalla, F | 1 |
| Sudy, E | 1 |
| Pelak, BA | 1 |
| Bartizal, K | 1 |
| Woods, GL | 1 |
| Gesser, RM | 1 |
| Motyl, M | 1 |
| Dan, M | 1 |
| Serour, F | 1 |
| Poch, F | 1 |
| Donnelly, JP | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| Kocagöz, T | 1 |
| Akalin, HE | 1 |
| Nathwani, D | 1 |
| Laing, RB | 1 |
| Harvey, G | 1 |
| Smith, CC | 1 |
| Hyatt, DS | 1 |
| Rogers, TR | 1 |
| McCarthy, DM | 1 |
| Samson, DS | 1 |
| Piccolomini, R | 1 |
| Di Girolamo, A | 1 |
| Iacone, A | 1 |
| Fioritoni, G | 1 |
| Cellini, L | 1 |
| Nicoletti, M | 1 |
| D'Antonio, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Population Pharmacokinetics of Anti-infective Drugs in Children in Anti-infectious Therapies[NCT03113344] | 800 participants (Anticipated) | Observational [Patient Registry] | 2017-06-21 | Recruiting | |||
| Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious Diseases[NCT03643497] | 800 participants (Anticipated) | Observational [Patient Registry] | 2018-07-01 | Recruiting | |||
| Antimicrobial Resistance Profiles in Healthcare Facilities From Meta State, Colombia: A Retrospective Observational Study From 2018-2022[NCT06044272] | 10,000 participants (Anticipated) | Observational | 2023-09-30 | Not yet recruiting | |||
| Impact of Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient Setting: a Protocol for a Pragmatic, Prospective Quasi-experimental Trial[NCT03612297] | 64,000 participants (Anticipated) | Observational | 2018-09-01 | Not yet recruiting | |||
| The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients[NCT01551186] | Phase 4 | 103 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia : a Randomized Controlled Study (iDIAPASON)[NCT02634411] | 190 participants (Actual) | Interventional | 2016-06-03 | Completed | |||
| Randomized Trial of Standard vs. Enhanced Hydration in Patients With a Diagnosis of Acute Pancreatitis Within the First Hour of the Diagnosis[NCT02709044] | Phase 2/Phase 3 | 903 participants (Anticipated) | Interventional | 2016-02-29 | Recruiting | ||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Colonization of the gastrointestinal tract with C. difficile, vancomycin-resistant enterococci, multidrug-resistant Acinetobacter baumannii, and multidrug- resistant Pseudomonas. Colonization occurs when the subject acquires the above organism while in the study. (NCT01551186)
Timeframe: Participants will be followed while Intubated, an expected average of 7 days. The outcome will be measured 3 days after enrollment and at the end of intubation, average time 7 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Probiotic | 8 |
| Standard of Care | 8 |
16 reviews available for ciprofloxacin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Hematopoietic neoplasms accompanied by severe enterocolitis due to Aeromonas species.
Topics: Aeromonas; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Diarrhea; Enterocoliti | 2017 |
Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature.
Topics: Aeromonas; Breast Diseases; Child; Ciprofloxacin; Dominican Republic; Female; Folliculitis; Gram-Neg | 2017 |
Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model.
Topics: Anaphylaxis; Anti-Bacterial Agents; Ciprofloxacin; Decision Trees; Drug Hypersensitivity; Gram-Negat | 2011 |
Inhaled antibiotics in cystic fibrosis: what's new?
Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Pr | 2012 |
Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Gram-Negative Bacterial Infections; | 2012 |
Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Ciprofloxacin; Drug | 2013 |
Eikenella corrodens discitis after spinal surgery: case report and literature review.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Discitis; Eikenella corrodens; Gram-Negative Bacterial | 2002 |
Microbial keratitis and vision loss with contact lenses.
Topics: Adult; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulc | 2003 |
Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Gram-Negati | 2004 |
Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
Topics: Abdominal Abscess; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negative Ba | 2004 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community- | 2006 |
[Bacteria of the genus Arcobacter, a new etiological factor of nosocomial infections].
Topics: Animals; Arcobacter; Bacteriological Techniques; Ciprofloxacin; Cross Infection; Erythromycin; Gram- | 2006 |
Quinolone therapy in intensive care unit settings.
Topics: Administration, Oral; Aged; Ciprofloxacin; Clinical Protocols; Clinical Trials as Topic; Cross Infec | 1993 |
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluo | 1993 |
Rahnella aquatilis bacteremia in an HIV-infected intravenous drug abuser.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Gram-Ne | 1995 |
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Breast Neoplasms; Ciprofloxacin; Dr | 1997 |
20 trials available for ciprofloxacin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bac | 2008 |
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press | 2014 |
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press | 2014 |
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press | 2014 |
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press | 2014 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; | 2013 |
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Gram-Negative Bacter | 2004 |
Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cytokines; Female; G | 2004 |
Clinical effect of intravenous ciprofloxacin on hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bac | 2005 |
Short-term antibiotic prophylaxis in implant surgery: a comparison of three antibiotics.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cefuroxime; Cip | 2007 |
Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis.
Topics: Adult; Chronic Disease; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Gram-Positive Bac | 1994 |
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infect | 1993 |
Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
Topics: Adult; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary | 1993 |
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown | 1995 |
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Com | 1997 |
Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections.
Topics: Adult; Aged; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Creatinine; Critical Car | 1998 |
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Me | 1999 |
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.
Topics: Administration, Oral; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Cre | 2000 |
Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation.
Topics: Administration, Oral; Adsorption; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biofilms; C | 2001 |
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.
Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Dru | 2001 |
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therap | 1992 |
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gra | 1991 |
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
Topics: Adult; Aged; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; G | 1991 |
195 other studies available for ciprofloxacin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Micro | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; | 2008 |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
Topics: Aeromonas; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; M | 2008 |
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infe | 2008 |
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Prim | 2008 |
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial | 2008 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; | 2009 |
Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Gram-Ne | 2010 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacte | 2011 |
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Gram-Negative Bacteria; Gra | 2012 |
'The Violet Killer'-Successful Treatment of an Infant with Chromobacterium violaceum Sepsis.
Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; I | 2021 |
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; | 2022 |
Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Gram-Negative Bacterial Infections; HIV Infections | 2022 |
Induction of Antimicrobial Resistance of
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative Bacteri | 2023 |
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
Topics: A549 Cells; Administration, Inhalation; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Combina | 2020 |
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Ciprofloxacin; Cloxacillin; D | 2020 |
Successful conservative treatment of necrotizing fasciitis associated with Aeromonas veronii in a patient with acute myeloid leukemia.
Topics: Aeromonas veronii; Aged; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Combined Modality Therapy; | 2020 |
Francisella novicida and F. philomiragia biofilm features conditionning fitness in spring water and in presence of antibiotics.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Conserved Sequence; DNA, | 2020 |
Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Ceftazidime; China; Ciprofloxacin; Drug | 2020 |
Antimicrobial resistance and virulence genes profiles of Arcobacter butzleri strains isolated from back yard chickens and retail poultry meat in Chile.
Topics: Animals; Anti-Bacterial Agents; Arcobacter; Chickens; Chile; Ciprofloxacin; Drug Resistance, Bacteri | 2021 |
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; | 2017 |
Multiple Liver Abscesses with a Skin Pustule due to Chromobacterium violaceum.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacte | 2017 |
Switchable Control of Antibiotic Activity: A Shape-Shifting "Tail" Strategy.
Topics: Acrylic Resins; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug | 2018 |
Leukoerythroblastosis in a Young Child with Severe Malaria and Superimposed Gram Negative Infection.
Topics: Anemia, Myelophthisic; Antimalarials; Blood Transfusion; Child, Preschool; Ciprofloxacin; Enterobact | 2018 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal | 2018 |
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cupriavidus; Drug Resistance, Bacterial; Drug Therap | 2018 |
Plasmid-Mediated Quinolone Resistance in Gram-Negative Pathogens Isolated from Cancer Patients in Egypt.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Egypt; | 2018 |
Necrotizing Pneumonia Caused by
Topics: Anti-Bacterial Agents; Child; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacterial Infect | 2018 |
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Gram-Negative B | 2018 |
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacte | 2018 |
Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparatio | 2018 |
Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Carrier State; Cip | 2019 |
Bacteremia by Chryseobacterium oranimense, A Colistin-Resistant Gram-Negative Bacilli, in an Immunocompetent Pediatric Patient.
Topics: Anti-Bacterial Agents; Autistic Disorder; Bacteremia; Child; Chryseobacterium; Ciprofloxacin; Colist | 2019 |
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug C | 2019 |
Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Apoproteins; Ciprofloxacin; Drug Resistance, Bacteri | 2019 |
The role of leech water sampling in choice of prophylactic antibiotics in medical leech therapy.
Topics: Aeromonas hydrophila; Amputation, Traumatic; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; | 2013 |
Otogenic cerebellar abscess by Enterococcus avium, a very rare infectious agent.
Topics: Acetamides; Anti-Bacterial Agents; Brain Abscess; Cerebellar Diseases; Ciprofloxacin; Enterococcus; | 2013 |
A persistent, symptomatic urinary tract infection with multiple "negative" urine cultures.
Topics: Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negati | 2013 |
The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Comorbid | 2013 |
Two cases of Kerstersia gyiorum isolated from sites of chronic infection.
Topics: Alcaligenaceae; Anti-Bacterial Agents; Bacteriological Techniques; Chronic Disease; Ciprofloxacin; D | 2013 |
Bacteremia due to Aeromonas hydrophila in acute lymphoblastic leukemia.
Topics: Acute Disease; Aeromonas hydrophila; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Fever | 2013 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Ciprofloxacin-resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases.
Topics: Adult; Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacteri | 2014 |
Ornamental fish as a source of plasmid-mediated quinolone resistance genes and antibiotic resistance plasmids.
Topics: Aeromonas; Animals; Anti-Bacterial Agents; Aquaculture; Base Sequence; Blotting, Southern; Carps; Ci | 2014 |
Acute prostatitis caused by Raoultella planticola in a renal transplant recipient: a novel case.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial | 2014 |
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; Ciprofloxacin; Debridement; Female; Gram- | 2014 |
Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.
Topics: Anti-Bacterial Agents; Bacteremia; British Columbia; Ciprofloxacin; Drug Resistance, Bacterial; Ente | 2014 |
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxac | 2015 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; C | 2015 |
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female; | 2015 |
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; China; Ciprofloxacin; Cross Infection; | 2015 |
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Fece | 2015 |
[Urinary tract infection associated with Delftia acidovorans].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Delftia acidovorans; Drug Resistance, Microbial; Female; | 2015 |
Occurrence and antimicrobial resistance of emergent Arcobacter spp. isolated from cattle and sheep in Iran.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Arcobacter; Carrier State; Cattle; Cattle Diseases; Cipro | 2016 |
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia.
Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnos | 2016 |
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus.
Topics: Anti-Bacterial Agents; Antibiosis; Bdellovibrio; Biofilms; Ciprofloxacin; Environmental Microbiology | 2016 |
Shewanella algae bacteremia from a foot ulcer exposed to seawater during a Caribbean vacation.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Caribbean Region; Ciprofloxacin; Diabetes Mellitus, Type 2; | 2016 |
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Commu | 2016 |
Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Ba | 2016 |
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Bacterial; Gra | 2016 |
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; | 2017 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacteri | 2016 |
Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; | 2017 |
Stenotrophomonas maltophilia isolated from prostatic fluid as an infertility factor in a male dog.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Gram-Negative Bacterial Infection | 2017 |
Investigation of plasmid-mediated quinolone resistance among isolates obtained in a Turkish intensive care unit.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative | 2008 |
Post-operative endophthalmitis due to an unusual pathogen, Comamonas testosteroni.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Ciprofloxacin; Comamonas | 2009 |
[Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cellulitis | 2009 |
Ochrobactrum anthropi septic arthritis of the acromioclavicular joint in an immunocompetent 17 year old.
Topics: Acromioclavicular Joint; Adolescent; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty; Cip | 2008 |
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.
Topics: Adult; Aortic Valve; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Echocardiography, Tr | 2009 |
Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Topics: Anti-Infective Agents; Argentina; Biofilms; Ciprofloxacin; Cross Infection; Drug Resistance, Multipl | 2009 |
[Leech-borne infection on a TRAM flap: a case report].
Topics: Aeromonas hydrophila; Cephalosporins; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Hum | 2010 |
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.
Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bact | 2009 |
The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice.
Topics: Animals; Anti-Infective Agents; Bacterial Translocation; Cholagogues and Choleretics; Ciprofloxacin; | 2009 |
Ecological effects of selective decontamination on resistant gram-negative bacterial colonization.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Cross Infection; Drug Res | 2010 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Age | 2010 |
Treatment of Stenotrophomonas neonatal urinary tract infection with instillation of ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; M | 2010 |
Quinolone-resistant Aeromonas hydrophila peritonitis in a CAPD patient.
Topics: Adult; Aeromonas hydrophila; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bac | 2010 |
The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
Topics: Acinetobacter; Anti-Infective Agents; Burn Units; Ceftazidime; Ciprofloxacin; Drug Resistance, Multi | 2010 |
Infection caused by Rahnella aquatilis.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Catheterization, Central Venous; Ciprofloxacin; E | 2010 |
In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negat | 2010 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug | 2010 |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Ba | 2011 |
Late-onset intrascleral dissemination of Stenotrophomonas maltophilia scleritis after pterygium excision.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Debridement; Eye Infections, Bacterial; Female; Gram-Neg | 2011 |
Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistanc | 2011 |
Patterns of ciprofloxacin-resistant gram-negative bacteria colonization in nursing home residents.
Topics: Anti-Infective Agents; Carrier State; Ciprofloxacin; Cognition Disorders; Comorbidity; Cross-Section | 2011 |
Nonpigmented Chromobacterium violaceum bacteremic cellulitis after fish bite.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Bites and Stings; Cellulitis; Chromob | 2011 |
Comamonas testosteroni infection in Taiwan: Reported two cases and literature review.
Topics: Aged; Alcoholism; Anti-Bacterial Agents; Bacteremia; Carcinoma, Hepatocellular; Cellulitis; Cephalos | 2011 |
Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciproflo | 2011 |
Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacter | 2011 |
Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; ATP-Binding Cassette Transporters; Ciprofloxa | 2011 |
Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia.
Topics: Alleles; Anti-Infective Agents; Bacterial Proteins; Bacterial Typing Techniques; Ciprofloxacin; Drug | 2012 |
Photo quiz: A 36-year-old with recurrent conjunctivitis.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacterial Typing Techniques; B | 2012 |
Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Ceftriaxone; Ciprofloxacin; Cross In | 2011 |
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Dru | 2012 |
[A rare cause of pneumonia: Shewanella putrefaciens].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiectasis; Ceftazidime; Ceftriaxone; Cipro | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; | 2012 |
Bacteriological agents of chronic discharging ears and their antibiotic sensitivity pattern in Ido - Ekiti, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Child; C | 2012 |
Arcobacter species in diarrhoeal faeces from humans in New Zealand.
Topics: Adult; Aged; Ampicillin; Arcobacter; Child, Preschool; Ciprofloxacin; Diarrhea; Erythromycin; Feces; | 2012 |
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.
Topics: Aged; Ciprofloxacin; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Multiple, | 2012 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacteri | 2013 |
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Gene Expression; Genes, | 2013 |
Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteri | 2012 |
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Cellulitis; Child; Ciprofloxacin; Drug Resista | 2013 |
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cancer Care Facilities; Ciprofloxacin; Drug Resistance, Bacterial | 2013 |
Clinical presentation of microbial keratitis with daily wear frequent-replacement hydrogel lenses: a case series.
Topics: Adolescent; Adult; Aeromonas; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Hydrophilic; Eye | 2002 |
Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Ba | 2002 |
Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Infant, Ne | 2002 |
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; | 2003 |
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Age | 2003 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxi | 2003 |
Isolation and antimicrobial susceptibility of Aeromonas salmonicida in rainbow trout (Oncorhynchus mykiss) in turkey hatchery farms.
Topics: Aeromonas; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fish Diseases; | 2003 |
[Necrotizing otitis externa caused by Stenotrophomonas maltophilia].
Topics: Anti-Infective Agents; Bacteriological Techniques; Biopsy; Ciprofloxacin; Cross Infection; Dose-Resp | 2003 |
Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacteremia; Bone Marrow Transplantation; Case-Control Stu | 2004 |
Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bile Ducts, Intrahepatic; Biliary Tract Surgi | 2003 |
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Ba | 2004 |
An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
Topics: Aeromonas; Anti-Infective Agents; Base Sequence; Ciprofloxacin; Diarrhea; DNA Gyrase; DNA Topoisomer | 2004 |
Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Ciprofloxacin; Cystic Fibrosis; Female; | 2005 |
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Mul | 2005 |
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteri | 2005 |
Aeromonas veronii biovar sobria bacteraemia with septic arthritis confirmed by 16S rDNA PCR in an immunocompetent adult.
Topics: Aeromonas; Aged, 80 and over; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Ciprofloxaci | 2006 |
Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Gram-Negativ | 2006 |
Effectiveness of flouroquinolone therapy for gram-negative infections within the intensive care unit setting.
Topics: Acinetobacter; Alabama; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia | 2006 |
Post-ERCP bacteremia caused by Alcaligenes xylosoxidans in a patient with pancreas cancer.
Topics: Aged; Alcaligenes; Anti-Infective Agents; Bacteremia; Cholangiopancreatography, Endoscopic Retrograd | 2006 |
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalos | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; | 2006 |
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Ciprofloxacin; Cross Infection; Dr | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefe | 2007 |
Pyrosequencing of the DNA gyrase gene in Neisseria species: effective indicator of ciprofloxacin resistance in Neisseria gonorrhoeae.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA, Bacterial | 2006 |
Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients.
Topics: Adult; Aged; Anti-Infective Agents; Canada; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacteria | 2007 |
Nucleotide sequence of the gyrA gene of Arcobacter species and characterization of human ciprofloxacin-resistant clinical isolates.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Arcobacter; Base Sequence; Camp | 2007 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinol | 2006 |
Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: implications in the fibrinolytic process.
Topics: Amikacin; Bacteriolysis; Bone Marrow Transplantation; Catheterization, Central Venous; Child; Ciprof | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infectio | 2007 |
Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis.
Topics: Animals; Carboxypeptidase B2; Ciprofloxacin; Enterococcus faecalis; Gram-Negative Bacterial Infectio | 2007 |
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; F | 2007 |
A possible new cause of spa bath folliculitis: Aeromonas hydrophila.
Topics: Adult; Aeromonas hydrophila; Alopecia; Anti-Bacterial Agents; Cicatrix; Ciprofloxacin; Filtration; F | 2008 |
Posttraumatic Stenotrophomonas maltophilia infectious scleritis.
Topics: Ciprofloxacin; Combined Modality Therapy; Conjunctiva; Drug Therapy, Combination; Eye Foreign Bodies | 2008 |
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Corneal Ulcer; Delftia acidovorans; Dru | 2008 |
Meningitis caused by Alcaligenes xylosoxidans in a patient with HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Gram-Negat | 2007 |
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri | 2008 |
Aeromonas hydrophila bacteraemia and portal pyaemia.
Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Gram-Negative Bacteria | 2008 |
Fluoroquinolone resistance during 2000-2005: an observational study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Community-Acquired Infec | 2008 |
Chronic diarrhea due to a single strain of Aeromonas caviae.
Topics: Aeromonas; Chronic Disease; Ciprofloxacin; Diarrhea; DNA, Bacterial; Feces; Gram-Negative Bacterial | 1995 |
Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria. The Spanish Study Group on Quinolone Resistance.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bac | 1995 |
Fluoroquinolones for the eye.
Topics: Chloramphenicol; Ciprofloxacin; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Human | 1994 |
[The efficacy of the clinical use of the preparation Cifran in treating surgical infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation; Female; Fluor | 1994 |
[Antibiotic treatment for pneumonia caused by Flavobacterium meningosepticum].
Topics: Aged; Aztreonam; Cefsulodin; Ciprofloxacin; Drug Therapy, Combination; Female; Flavobacterium; Gram- | 1994 |
Pharmacokinetics of ciprofloxacin in ponies.
Topics: Administration, Oral; Animals; Aqueous Humor; Biological Availability; Ciprofloxacin; Computer Simul | 1995 |
Antibacterial efficacy of ciprofloxacin in a case of endocarditis due to Cardiobacterium hominis.
Topics: Adult; Bacteria, Anaerobic; Blood Bactericidal Activity; Ciprofloxacin; Endocarditis, Bacterial; Gra | 1994 |
Prevalence of ciprofloxacin resistance in multiresistant gram-negative intensive care unit isolates.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Human | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cro | 1994 |
Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats.
Topics: Animals; Bacteremia; Ciprofloxacin; Cytomegalovirus Infections; Gram-Negative Aerobic Bacteria; Gram | 1994 |
Wound infection due to Aeromonas sobria.
Topics: Adult; Aeromonas; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Male; Water Microbiolog | 1993 |
Pseudoinfection of a total knee arthroplasty.
Topics: Aged; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Knee Prosthesis; Prosthesis | 1994 |
Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Neg | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resist | 1993 |
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Topics: Administration, Oral; Ciprofloxacin; Diarrhea; Gram-Negative Bacterial Infections; Humans; Respirato | 1994 |
The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negativ | 1993 |
Increased resistance to quinolone in Catalonia, Spain.
Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Microbial; Enteroba | 1993 |
The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid.
Topics: Ciprofloxacin; Escherichia coli Infections; Flavobacterium; Gram-Negative Bacterial Infections; Huma | 1993 |
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Res | 1995 |
Bacteremic necrotizing fasciitis due to Flavobacterium odoratum.
Topics: Aged; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Multiple; Fasciitis, Necrot | 1995 |
Antibiotic prophylaxis of ERCP with ciprofloxacin.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Cholangiopancreatography, Endoscopic Retrograde; Chol | 1996 |
Ochrobactrum anthropi endophthalmitis after uncomplicated cataract surgery.
Topics: Aged; Alcaligenes; Anterior Chamber; Anti-Infective Agents; Cataract Extraction; Ciprofloxacin; Endo | 1996 |
Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacterial Infections; Gram | 1996 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; | 1996 |
Severe knee arthritis due to Eikenella corrodens following a human bite.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, I | 1997 |
[Gram-negative bacilli isolated in a general hospital: high rate of ciprofloxacin resistance].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative | 1996 |
Endogenous Ochrobactrum anthropi endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Cat | 1997 |
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulani | 1996 |
Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Therapy; Ent | 1997 |
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ceftazidime; Cephalos | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C | 1997 |
A case of Plesiomonas shigelloides cellulitis and bacteraemia from northern Europe.
Topics: Aged; Anti-Infective Agents; Bacteremia; Cellulitis; Ciprofloxacin; Europe; Gram-Negative Bacterial | 1997 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins | 1998 |
Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility.
Topics: Aged; Anti-Infective Agents; California; Carrier State; Ciprofloxacin; Drug Resistance, Microbial; F | 1998 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negat | 1999 |
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; G | 1999 |
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocar | 2000 |
In vitro activity of difloxacin against canine bacterial isolates.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R | 2000 |
Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.
Topics: Aged; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Critical Care; Cross Infection; Cross-Sect | 2000 |
Aeromonas hydrophila infection secondary to an electrical burn.
Topics: Aeromonas hydrophila; Aged; Anti-Infective Agents; Burns, Electric; Ciprofloxacin; Female; Gentamici | 2000 |
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Dru | 2000 |
Comamonas acidovorans keratitis in a hydrogel contact lens wearer.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Delftia acidovorans; Eye | 2001 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Col | 2001 |
Successful treatment of an infant with Chromobacterium violaceum sepsis.
Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; H | 2001 |
Aeromonas sobria sepsis in a neutropenic patient.
Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxaci | 2001 |
Upper airway obstruction due to rhinoscleroma: case report.
Topics: Airway Obstruction; Anti-Infective Agents; Bronchoscopy; Ciprofloxacin; Dyspnea; Female; Gram-Negati | 2001 |
Opportunistic Roseomonas keratitis.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Eye Infections, Bacterial; Female; Gr | 2001 |
Pyoderma faciale: gram-negative recovery by means of needle aspiration.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Drainage; Enterobacter cloacae; Facia | 2002 |
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial | 2002 |
Penetration of ciprofloxacin into human peritoneal tissue following a single oral dose of 750 milligrams.
Topics: Abdomen; Administration, Oral; Adult; Aged; Animals; Ciprofloxacin; Cricetinae; Female; Gram-Negativ | 1992 |
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; | 1992 |
Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin.
Topics: Aeromonas hydrophila; Aged; Aged, 80 and over; Ciprofloxacin; Disease Outbreaks; Female; Gastroenter | 1991 |